Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in

C Trautwein1, T Rakemann, D A Brenner

  • 1Department of Gastroenterology and Hepatology, Medizinische Hochschule Hannover, Hannover, Germany.

Gastroenterology
|May 30, 1998
PubMed
Abstract

Insights

Concanavalin A (con A) triggers tumor necrosis factor (TNF)-dependent liver cell death, activating Jun kinase (JNK) and nuclear factor-kappaB (NF-κB) pathways. Blocking TNF with anti-TNF inhibits these pathways, offering therapeutic potential.

Area of Science:

  • Hepatology
  • Immunology
  • Molecular Biology

Background:

  • Concanavalin A (con A) administration induces hepatocyte apoptosis, mimicking human immune-mediated fulminant hepatic failure.
  • Tumor necrosis factor (TNF) signaling pathways are critical, leading to apoptosis, nuclear factor-kappaB (NF-κB) translocation, or Jun kinase (JNK) activation.

Purpose of the Study:

  • To investigate the specific TNF-dependent intracellular pathways activated following con A injection in vivo.
  • To elucidate the temporal relationship between JNK and NF-κB activation in this model.

Main Methods:

  • BALB/c mice were injected with con A, con A plus anti-TNF, or control buffer.
  • Techniques included immunofluorescence, Western blot, Northern blot, gel shift assays, and measurement of Erk and JNK activity and DNA fragmentation.

Main Results:

  • Con A induced hepatocyte DNA fragmentation between 4-24 hours post-injection.
  • JNK activation peaked (>20-fold) immediately after con A, while NF-κB translocation was maximal at 4 hours.
  • Anti-TNF treatment blocked all investigated pathways, though c-Jun nuclear expression and DNA binding persisted despite anti-TNF therapy.

Conclusions:

  • TNF-dependent pathway activation is intrinsically linked to hepatocyte apoptosis in the con A model.
  • Targeting these pathways in vivo holds promise for developing novel therapeutic strategies against liver apoptosis.